Skip to content

Indigenous Td Vaccine: Nadda Launches CRI Kasauli Jab

23 February 20261 min read
NATIONAL AFFAIRSIndigenous TdVaccine: NaddaLaunches CRIKasauli Jab23 February 2026safalsetu.com

Why in the news

Health Minister J.P. Nadda launched a home-grown Td vaccine, seen as a step towards self-reliance in vaccines and a stronger public health system.

Key facts

  • Product: Tetanus and Adult Diphtheria (Td) vaccine, indigenously manufactured.
  • Manufacturer: Central Research Institute (CRI), Kasauli.
  • Use: supplied through the Universal Immunization Programme (UIP).
  • Supply: 55 lakh doses by April 2026; production to grow over the coming years.
BodyKey points
Universal Immunization ProgrammeAmong the largest immunisation programmes worldwide; 11 vaccines against 12 diseases; run by the Government of India to lower child and maternal mortality
CRI, KasauliGovernment vaccine maker; first government facility to make vaccines under Good Manufacturing Practices (GMP); important in public sector vaccine output

Exam angle

  • Maker of the Td vaccine: CRI Kasauli.
  • UIP numbers: 11 vaccines, 12 diseases.
  • First government unit producing vaccines under GMP: CRI Kasauli.

Test yourself

1. Which institute manufactures the indigenous Td vaccine launched by J.P. Nadda?

The vaccine is produced by CRI, Kasauli.

2. Under which programme will the indigenous Td vaccine be supplied?

It will be supplied under the Universal Immunization Programme.

3. How many Td vaccine doses are to be supplied by April 2026?

The notes say 55 lakh doses are due by April 2026.